title: "Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome"
authors: Schramm A, Schowe B, Fielitz K, Heilmann M, Martin M, Marschall T, KÃ¶ster J, Vandesompele J, Vermeulen J, de Preter K, Koster J, Versteeg R, Noguera R, Speleman F, Rahmann S, Eggert A, Morik K, Schulte JH
text: https://doi.org/10.1038/bjc.2012.391
date: "2012-10-09"
journal: Br J Cancer
pubmed: 23047593
